CIK 0000320017 · Non-accelerated filer<br>Smaller reporting company
LISATA THERAPEUTICS, INC.
Sign in to watch- Ticker
- LSTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 222343568
- Phone
- 908-229-2590
- Business address
- 110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
- Former names
- Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
- 4 Shares withheld for taxes See Remarks gave up 4,791 shares (to pay taxes)
- 4 Grant or award Director acquired 18,292 shares (grant or award)
- 4 Grant or award Director acquired 18,292 shares (grant or award)
- 4 Grant or award Director acquired 18,292 shares (grant or award)
- 4 Grant or award Director acquired 18,292 shares (grant or award)
- 4 Grant or award Director acquired 18,292 shares (grant or award)
- 4 Shares withheld for taxes SVP and CFO gave up 1,821 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 4,522 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 1,821 shares (to pay taxes)
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- 8-K Event Results of operations · Regulation FD disclosure
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- 8-K/A Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
Page 16 of 80 · 1,585 filings